OBJECTIVE:Seventeen-alpha-hydroxyprogesterone caproate (17-OHPC) reduces recurrent preterm birth (PTB). We hypothesized that single nucleotide polymorphisms in the human progesterone receptor (PGR) affect response to 17-OHPC in the prevention of recurrent PTB. STUDY DESIGN: We conducted secondary analysis of a study of 17-OHPC vs placebo for recurrent PTB prevention. Twenty PGR gene single nucleotide polymorphisms were studied. Multivariable logistic regression assessed for an interaction between PGR genotype and treatment status in modulating the risk of recurrent PTB. RESULTS:A total of 380 women were included; 253 (66.6%) received17-OHPC and 127 (33.4%) received placebo. In all, 61.1% of women were African American. Multivariable logistic regression demonstrated significant treatment-genotype interactions (either a beneficial or harmful treatment response) for African Americans delivering<37 weeks' gestation for rs471767 and rs578029, and for Hispanics/Caucasians delivering<37 weeks' gestation for rs500760 and <32 weeks' gestation for rs578029, rs503362, and rs666553. CONCLUSION: The clinical efficacy and safety of 17-OHPC for recurrent PTB prevention may be altered by PGR gene polymorphisms.
RCT Entities:
OBJECTIVE:Seventeen-alpha-hydroxyprogesterone caproate (17-OHPC) reduces recurrent preterm birth (PTB). We hypothesized that single nucleotide polymorphisms in the humanprogesterone receptor (PGR) affect response to 17-OHPC in the prevention of recurrent PTB. STUDY DESIGN: We conducted secondary analysis of a study of 17-OHPC vs placebo for recurrent PTB prevention. Twenty PGR gene single nucleotide polymorphisms were studied. Multivariable logistic regression assessed for an interaction between PGR genotype and treatment status in modulating the risk of recurrent PTB. RESULTS: A total of 380 women were included; 253 (66.6%) received 17-OHPC and 127 (33.4%) received placebo. In all, 61.1% of women were African American. Multivariable logistic regression demonstrated significant treatment-genotype interactions (either a beneficial or harmful treatment response) for African Americans delivering<37 weeks' gestation for rs471767 and rs578029, and for Hispanics/Caucasians delivering<37 weeks' gestation for rs500760 and <32 weeks' gestation for rs578029, rs503362, and rs666553. CONCLUSION: The clinical efficacy and safety of 17-OHPC for recurrent PTB prevention may be altered by PGR gene polymorphisms.
Authors: C Blackmore-Prince; B Kieke; K A Kugaraj; C Ferré; L D Elam-Evans; C J Krulewitch; J A Gaudino; M Overpeck Journal: Matern Child Health J Date: 1999-12
Authors: Tracy A Manuck; Heather D Major; Michael W Varner; Rakesh Chettier; Lesa Nelson; M Sean Esplin Journal: Obstet Gynecol Date: 2010-04 Impact factor: 7.661
Authors: Thomas Morgan; Mert O Bahtiyar; Victoria V Snegovskikh; Frederick Schatz; Edward Kuczynski; Edmund F Funai; Antonette T Dulay; Se-Te Joseph Huang; Catalin S Buhimschi; Irina A Buhimschi; Stephen J Fortunato; Ramkumar Menon; Charles J Lockwood; Errol R Norwitz Journal: Reprod Sci Date: 2008-02 Impact factor: 3.060
Authors: Nicole L Ehn; Margaret E Cooper; Kristin Orr; Min Shi; Marla K Johnson; Diana Caprau; John Dagle; Katherine Steffen; Karen Johnson; Mary L Marazita; David Merrill; Jeffrey C Murray Journal: Pediatr Res Date: 2007-11 Impact factor: 3.756
Authors: Laura Diaz-Cueto; Pablo Dominguez-Lopez; Julio Cantillo-Cabarcas; Gloria Perez-Figueroa; Miguel Arechavaleta-Velasco; Fabian Arechavaleta-Velasco Journal: Int J Gynaecol Obstet Date: 2008-08-22 Impact factor: 3.561
Authors: Amy L Turitz; Jamie A Bastek; Stephanie E Purisch; Michal A Elovitz; Lisa D Levine Journal: Am J Obstet Gynecol Date: 2015-10-28 Impact factor: 8.661
Authors: Tracy A Manuck; Gregory J Stoddard; Rebecca C Fry; M Sean Esplin; Michael W Varner Journal: Am J Obstet Gynecol Date: 2016-07-11 Impact factor: 8.661
Authors: Tracy A Manuck; M Sean Esplin; Joseph Biggio; Radek Bukowski; Samuel Parry; Heping Zhang; Hao Huang; Michael W Varner; William Andrews; George Saade; Yoel Sadovsky; Uma M Reddy; John Ilekis Journal: Am J Obstet Gynecol Date: 2015-12-12 Impact factor: 8.661
Authors: Martha L Bustos; Steve N Caritis; Kathleen A Jablonski; Uma M Reddy; Yoram Sorokin; Tracy Manuck; Michael W Varner; Ronald J Wapner; Jay D Iams; Marshall W Carpenter; Alan M Peaceman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan M Ramin Journal: Am J Obstet Gynecol Date: 2017-05-15 Impact factor: 8.661